Photobiomodulation

Low-level laser therapy (LLLT), also known as photobiomodulation, involves the application of specific wavelengths of light to targeted areas of the brain, stimulating cellular activity and promoting beneficial neurochemical changes. LLLT has been found to modulate brain activity and promote neuroplasticity, which can lead to improvements in cognitive function and behavior. This therapy has been shown to enhance mitochondrial function, increase cerebral blood flow, and reduce inflammation, all of which are factors implicated in neurobehavioral disorders. Photobiomodulation has demonstrated positive effects on social interaction, communication, and sensory sensitivities. For individuals with ADHD, it has shown potential in improving attention span, impulse control, and executive functions.

Mitochondrial Function

Low-level laser therapy (LLLT) has the ability to enhance mitochondrial function, which is crucial for cellular energy production. By optimizing mitochondrial function through LLLT, children with neurobehavioral disorders such as Autism and ADHD may experience improved neurodevelopment, cognitive function, and behavior.

FDA Cleared

The laser used in low-level laser therapy (LLLT) is FDA cleared, ensuring its safety and efficacy for the treatment of various conditions, including neurobehavioral disorders such as Autism and ADHD. LLLT may facilitate neurogenesis and contribute to brain repair and regeneration, and can enhance mitochondrial function and increase energy production.

Neurogenesis

LLLT has been shown to promote neurogenesis, the formation of new neurons in the brain. LLLT can stimulate the release of neurotrophic factors, which are essential for the growth and survival of neurons. LLLT has also been shown to reduce inflammation and oxidative stress, which can inhibit neurogenesis. By creating an optimal cellular environment and promoting neurotrophic support, LLLT may facilitate neurogenesis and contribute to brain repair and regeneration.